TRANSIPURE
Food supplement declared in France, declaration No 2017-10-662, decision dated 25 October 2017
TRANSIPURE is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- LABORATOIRES HERBOLISTIQUE
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 6 gélules
- Not recommended for (according to the manufacturer)
- Sous traitement médicamenteux, Sous traitement pour la thyroïde
- Objectives stated by the manufacturer (these are not authorised claims)
- Transit
Declaration 205390, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Taraxacum campylodes G.E.Haglund | Racine | Poudre (de plantes séchées ou broyées) | 480 mg |
| Raphanus raphanistrum subsp. sativus (L.) Domin | Racine | Poudre (de plantes séchées ou broyées) | 480 mg |
| Plantago ovata Forssk. | Tégument | Poudre (de plantes séchées ou broyées) | 420 mg |
| Chlorella vulgaris Beijerinck | Thalle | Poudre (de plantes séchées ou broyées) | 300 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.
Label warnings
Consulter un professionnel de santé
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- TRANSIPURE HTA CARE, declared in 2016 : different composition: 2 ingredient(s) added, 4 missing
- TRANSIPURE PHYSIOMINS, declared in 2016 : different composition: 2 ingredient(s) added, 4 missing
- TRANSIPURE RELOOKING, declared in 2016 : different composition: 2 ingredient(s) added, 4 missing